Results 171 to 180 of about 22,842 (183)

The effects of human CYP2C8 genotype and fluvoxamine on the pharmacokinetics of rosiglitazone in healthy subjects

British Journal of Clinical Pharmacology, 2006
Kim Brosen, Per Damkier
exaly  

Cardiac safety profile of rosiglitazone

International Journal of Cardiology, 2010
Francesca Gori, Matteo Monami, Edoardo Mannucci   +2 more
exaly  

Rosiglitazone reduces urinary albumin excretion in type II diabetes

Journal of Human Hypertension, 2003
George Bakris, G Viberti, M I Freed
exaly  

A one-year study comparing the efficacy and safety of rosiglitazone and glibenclamide in the treatment of type 2 diabetes

Nutrition, Metabolism and Cardiovascular Diseases, 2007
Markolf Hanefeld, Nigel P Jones
exaly  

Rosiglitazone inhibits endothelial proliferation and angiogenesis

Life Sciences, 2006
Hsiu-Chung Ou, Wayne Sheu, Fen-Pi Chou   +2 more
exaly  

Rosiglitazone and Pioglitazone for the Treatment of Alzheimer's Disease

Annals of Pharmacotherapy, 2011
Kristine C Willett, Alicia R Desilets
exaly  

Rosiglitazone saga. Demonisation of rosiglitazone.

BMJ (Clinical research ed.), 2011
openaire   +1 more source

Rosiglitazone

Reactions Weekly, 2012
openaire   +1 more source

Rosiglitazone

Reactions Weekly, 2004
openaire   +1 more source

Efficacy and safety of rosiglitazone plus metformin in Mexicans with type 2 diabetes

Diabetes/Metabolism Research and Reviews, 2002
exaly